Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients
Oncotype Dx is used to determine the recurrence risk (RR) in patients with estrogen receptor positive (ER+) and lymph node negative (LN−) breast cancer. The RR is divided into low (0–17), intermediate (18–30), and high (31) to predict chemotherapy benefit. Our goal was to determine the association b...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2017-01-01
|
| Series: | International Journal of Breast Cancer |
| Online Access: | http://dx.doi.org/10.1155/2017/1257078 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832556161357840384 |
|---|---|
| author | Matthew G. Hanna Ira J. Bleiweiss Anupma Nayak Shabnam Jaffer |
| author_facet | Matthew G. Hanna Ira J. Bleiweiss Anupma Nayak Shabnam Jaffer |
| author_sort | Matthew G. Hanna |
| collection | DOAJ |
| description | Oncotype Dx is used to determine the recurrence risk (RR) in patients with estrogen receptor positive (ER+) and lymph node negative (LN−) breast cancer. The RR is divided into low (0–17), intermediate (18–30), and high (31) to predict chemotherapy benefit. Our goal was to determine the association between histomorphology, immunohistochemistry, and RR. We retrospectively identified 536 patients with ER+ and LN− breast cancers that underwent Oncotype testing from 2006 to 2013. Tumor size ranged from 0.2 cm to 6.5 cm (mean = 1.3 cm) and was uniform in all 3 categories. The carcinomas were as follows: ductal = 63.2%, lobular = 11.1%, and mixed = 35.7%. The RR correlated with the Nottingham grade. Increasing RR was inversely related to PR positivity but directly to Her2 positivity. Of the morphologic parameters, a tubular(lobular) morphology correlated only with low-intermediate scores and anaplastic type with intermediate-high scores. Other morphologies like micropapillary and mucinous were uniformly distributed in each category. Carcinomas with comedo intraductal carcinoma were more likely associated with high RR. Forty-four patients with either isolated tumor cells or micrometastases were evenly distributed amongst the 3 RR. While there was only 1 ER discrepancy between our immunohistochemistry (3+ 80%) and Oncotype, up to 8% of PR+ cases (mean = 15%, median = 5%) and 2% of HER2+ cases were undervalued by Oncotype. |
| format | Article |
| id | doaj-art-c5efee5ef7d94381b7ae2a792621251c |
| institution | Kabale University |
| issn | 2090-3170 2090-3189 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | International Journal of Breast Cancer |
| spelling | doaj-art-c5efee5ef7d94381b7ae2a792621251c2025-02-03T05:46:15ZengWileyInternational Journal of Breast Cancer2090-31702090-31892017-01-01201710.1155/2017/12570781257078Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 PatientsMatthew G. Hanna0Ira J. Bleiweiss1Anupma Nayak2Shabnam Jaffer3Department of Pathology, University of Pittsburgh, School of Medicine, S-417 BST, 200 Lothrop Street, Pittsburgh, PA 15261, USADepartment of Pathology, Hospital of the University of Pennsylvania, University of Pennsylvania, Founders 6, 3400 Spruce St., Philadelphia, PA 19104, USADepartment of Pathology, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Pl., P.O. Box 1194, New York, NY 10029, USADepartment of Pathology, Icahn School of Medicine at Mount Sinai, One Gustave L Levy Pl., P.O. Box 1194, New York, NY 10029, USAOncotype Dx is used to determine the recurrence risk (RR) in patients with estrogen receptor positive (ER+) and lymph node negative (LN−) breast cancer. The RR is divided into low (0–17), intermediate (18–30), and high (31) to predict chemotherapy benefit. Our goal was to determine the association between histomorphology, immunohistochemistry, and RR. We retrospectively identified 536 patients with ER+ and LN− breast cancers that underwent Oncotype testing from 2006 to 2013. Tumor size ranged from 0.2 cm to 6.5 cm (mean = 1.3 cm) and was uniform in all 3 categories. The carcinomas were as follows: ductal = 63.2%, lobular = 11.1%, and mixed = 35.7%. The RR correlated with the Nottingham grade. Increasing RR was inversely related to PR positivity but directly to Her2 positivity. Of the morphologic parameters, a tubular(lobular) morphology correlated only with low-intermediate scores and anaplastic type with intermediate-high scores. Other morphologies like micropapillary and mucinous were uniformly distributed in each category. Carcinomas with comedo intraductal carcinoma were more likely associated with high RR. Forty-four patients with either isolated tumor cells or micrometastases were evenly distributed amongst the 3 RR. While there was only 1 ER discrepancy between our immunohistochemistry (3+ 80%) and Oncotype, up to 8% of PR+ cases (mean = 15%, median = 5%) and 2% of HER2+ cases were undervalued by Oncotype.http://dx.doi.org/10.1155/2017/1257078 |
| spellingShingle | Matthew G. Hanna Ira J. Bleiweiss Anupma Nayak Shabnam Jaffer Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients International Journal of Breast Cancer |
| title | Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients |
| title_full | Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients |
| title_fullStr | Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients |
| title_full_unstemmed | Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients |
| title_short | Correlation of Oncotype DX Recurrence Score with Histomorphology and Immunohistochemistry in over 500 Patients |
| title_sort | correlation of oncotype dx recurrence score with histomorphology and immunohistochemistry in over 500 patients |
| url | http://dx.doi.org/10.1155/2017/1257078 |
| work_keys_str_mv | AT matthewghanna correlationofoncotypedxrecurrencescorewithhistomorphologyandimmunohistochemistryinover500patients AT irajbleiweiss correlationofoncotypedxrecurrencescorewithhistomorphologyandimmunohistochemistryinover500patients AT anupmanayak correlationofoncotypedxrecurrencescorewithhistomorphologyandimmunohistochemistryinover500patients AT shabnamjaffer correlationofoncotypedxrecurrencescorewithhistomorphologyandimmunohistochemistryinover500patients |